Overview

Respiratory syncytial virus (RSV) is a potentially-deadly disease in young children and infants at high risk. Despite clear guidelines from the American Academy of Pediatrics, many children who meet the criteria for RSV prophylaxis are not receiving it. Health-system pharmacists play a key role as preventive health advocates, including making preventive strategies available through formulary decisions, determining the use of those strategies, and educating patients and caregivers.

This webcourse will help to close educational gaps among health-system pharmacists by providing practical information facilitating state-of-the-art care in their hospitals and health systems. The ultimate goal of this activity is to help health-system pharmacists become more aware of the management challenges and prevention strategies available for RSV, and provide the best possible care to their youngest patients.

Faculty

	Faculty	Faculty Disclosures
	Renee F. Robinson, PharmD, MPH (Chair) Regional Clinical Manager Pharmacy Systems, Inc. Dublin, OH	Renee F. Robinson, PharmD, MPH Nothing to disclose
	Paul A. Checchia, MD, FAAP, FCCM Chief, Pediatric Cardiac Critical Care Service Medical Director, Pediatric Cardiac Intensive Care Unit St. Louis Children's Hospital Washington University School of Medicine St. Louis, MO	Paul A. Checchia, MD, FAAP, FCCM Speaker: MedImmune, Inc. Expert Advisory Panel: INO Therapeutics Inc., IKARIA Inc. Consultant: DRIVE Medical Consulting & Communications
	Michael Forbes, MD Pediatric & Adolescent Intensivist Director, Clinical Research and Outcomes Analysis Akron Children's Hospital Akron, OH	Michael Forbes, MD Consultant: MedImmune, Inc.

Target Audience

This program was developed for pharmacists.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Review the burden related to RSV infections, including cost and morbidity
• Discuss and explain the challenges in managing severe RSV infections
• Describe the vario us prevention strategies to decrease morbidity and mortality from RSV infections
• Demonstrate the ability to identify high-risk individuals for RSV complications according to the AAP guidelines

Accreditation Statement

The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.5 hours (0.15 CEUs) of continuing education credit (program number 418-000-08-002-L01).

Participants will receive statement of credit after attending the activity and completing an activity evaluation form, within four to six weeks of the program.

Disclosure

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

The following staff members of the Potomac Center for Medical Education involved in the development of content for this activity disclosed that they have no relevant financial relationships: Laurie Frueh, MD, Medical Science Liaison, Stephanie Stowell, MPhil, Medical Writer, Donna Fucello, Vice President, Clinical Education Division & Accreditation Services, Blair St. Amand, Editor, Ryan Nguyen, PharmD, external medical reviewer.

Fee Statement

There is no fee or refund associated with participating in this activity.

FDA Disclosure

The contents of some CME/CE activities may contain discussions of non-approved or off label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Sponsored by Supported by an educational grant from MedImmune, Inc.

By clicking this button you are agreeing that you have read and understood the CE/CME Statements above